BIGBEAR
PHARMACEUTICALS
Binimetinib is a targeted anti-cancer drug that works by blocking the MEK protein (a key protein that stimulates cancer cell growth) within cancer cells, thereby inhibiting tumor growth.
AuthenticGuaranteeFast DeliveryPrivacy On October 12, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved cannefenib in combination with bimetinib for the t···【Read More】
Update: 05 Mar,2026Source: Haiou HealthViews: 72
On June 27, 2018, the U.S. Food and Drug Administration (FDA) approved the combination of encorafenib and binimetinib for the treatment of patients wi···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 72
Copyright2024@ BIGBEAR All right reserved BIGBEAR
